Will China's yuan devaluation hit pharma's H2?; Aussie lawmaker accuses Big Pharma of hiding behind privacy rules;

@FiercePharma: ICYMI from FiercePharmaAsia: GeneWeave fits China antibiotic resistance fight, Decheng says. More | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Sun U.S. sales gut-kicked by supply constraints as it works on FDA concerns at Halol plant. Story | Follow @EricPFierce

@CarlyHFierce: Probing lawmakers grill Valeant on price hikes. FiercePharma article | Follow @CarlyHFierce

> With China's devaluation of the yuan last week, pharma's hopes for a better second half in the country have come under threat. Report

> Big Pharma is misusing Australian privacy laws to avoid taxes, a Labor senator contends. Report

> Roche's ($RHHBY) cancer immunotherapy shrank lung cancer tumors in a Phase II study, putting the company one step closer to winning FDA approval for its "breakthrough" designated med. Release

> Biogen ($BIIB) said an extension study reinforced the long-term benefits of its hemophilia B drug Alprolix. Release

Medical Device News

@FierceMedDev: Myriad snags Medicare coverage for prostate cancer test. News from FierceDiagnostics | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Bad news in California: Boston Sci to close to two facilities, Abbott cuts 160+ employees. Report | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: NOWDiagnostics gets FDA blessing for one-step pregnancy test. Story | Follow @EmilyWFierce

> GE gets FDA nod for low-dose computer CT lung cancer screening device. Story

> FDA: International regs don't protect patients from contaminated intraocular lenses. Article

Biotech News

@FierceBiotech: Hunting a fast approval in lung cancer, Roche racks up a positive PhII for 'atezo.' Article | Follow @FierceBiotech

@JohnCFierce: Heard the latest Kite rumor? CEO says it ain't so. More | Follow @JohnCFierce

> FDA confronts the Addyi dilemma: Yes or no on female libido pill? Story

> Retrophin goes after Shkreli with a $65M suit, claims of flagrant mismanagement. Report

> Novartis bets on a slumping Aveo in a $326M cancer deal. News

Animal Health News

> ImmuCell Q2 sales up, but not at levels reached earlier in the year. Item

> Merck debuts Fortegra in South America to combat coccidiosis in broilers. Story

> Frozen raw cat food recall by Northwest Farm Food Coop. More

> Parnell Pharmaceuticals says first-half losses narrow as it gears up pipeline. Report

> In wake of bird flu, Minnesota turkey producers slowly restocking flocks. Article

Biotech IT News

> Soon-Shiong allies with PA biomedical centers to further genomic research. News

> FDA adds alerts to Android drug shortages app. Item

> Google hooks up with DexCom to apply miniaturized electronics to diabetes monitoring. Story

> Trader accused of using hacked newswires to make $2.3M from Dendreon implosion. Article

> BioClinica makes eClinical suite available through a range of cloud options. Report

Pharma Marketing News

> FDA approves Purdue's controversial OxyContin for kids aged 11 to 16. Item

> Mylan hopes Disney can add new magic to its allergy-fighting kingdom. Report

> BMS revives Orencia DTC advertising after two-year absence. Story

> Has Kim Kardashian ruined pharma marketing, too? Fallout from the infamous Instagram post. More

> Sanofi adds its sales heft to Relypsa's forthcoming patiromer launch. Article

And Finally... The mushrooming number of diabetes cases could bankrupt England's National Health Service, a U.K. disease charity says. Report

Suggested Articles

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

Pfizer struck a deal to produce Gilead Sciences' remdesivir, which has been running short at some hard-hit U.S. hospitals.